非病毒性微生物性角膜炎实验室诊断进展
微生物性角膜炎是需紧急处理的眼睛急症,全球角膜盲负担仍较高,热带中低收入国家年患病率显著高于欧美。成功治疗依赖早期病原学诊断,本文综述非病毒性微生物性角膜炎的实验室诊断进展。
要点
- 微生物性角膜炎需紧急治疗,早期病原诊断是治疗成功的关键。
- 热带中低收入国家年患病率113–362/10万,约为北美和欧洲的10倍。
核心结论
- 微生物性角膜炎的成功治疗依赖于对病原体的早期诊断。
- 全球角膜盲负担有所下降,但热带中低收入国家患病率仍显著高于欧美。
研究设计与样本
- 本文为综述,检索范围未在原文中明确报告。
主要发现
- 热带中低收入国家年患病率报告为113–362/10万,是北美和欧洲的10倍。
- 该病在较贫困的农村和农业地区负担更高。
临床怎么用
- 临床诊断依据角膜溃疡伴或不伴基质浸润,可伴前房反应、结膜充血和前房积脓。
- 微生物性角膜炎作为眼科急症需紧急处理,并应尽早进行病原学诊断以指导治疗。
局限性
- 原文指出各地区实际疾病负担难以确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Introduction Microbial keratitis (MK) is an ocular emergency that needs urgent treatment. Clinically, the disease is diagnosed by the presence of corneal ulceration with or without underlying stromal infiltration. Anterior chamber reaction, conjunctival congestion and hypopyon may be present. Worldwide corneal blindness due to MK has decreased in recent times from 1.6 million in 1990 to 1.3 million in 2015. 1 2 The prevalence in low- and middle-income countries in the tropics is reported to range annually between 113 and 362 per 100,000, which is 10 times higher than that reported in North America and Europe. 3 4 The region-wise actual burden is difficult to determine; however, the burden is higher in poorer rural and agricultural areas. 5 Successful treatment of MK is dependent on early diagnosis of the aetiological agent. As is true for any other infection, the management of MK begins...
引用
- British Journal of Ophthalmology:Advances in the laboratory diagnosis of non-viral microbial keratitis
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。